Inventor
CHEN XIAO TAO
US26 patents
⚠️ This page may combine multiple inventors who share the name “CHEN XIAO TAO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
TREVENA INC
11 patentsUS9849119B2Dec 26, 2017
Opioid receptor ligands and methods of using and making same
TREVENA INC6 citations83
US9642842B2May 9, 2017
Opioid receptor ligands and methods of using and making same
TREVENA INC6 citations83
US9534017B2Jan 3, 2017
Beta-arrestin effectors and compositions and methods of use thereof
TREVENA INC3 citations83
US9309234B2Apr 12, 2016
Opioid receptor ligands and methods of using and making same
TREVENA INC7 citations83
US8809260B2Aug 19, 2014
β-arrestin effectors and compositions and methods of use thereof
TREVENA INC7 citations83
US8796204B2Aug 5, 2014
β-arrestin effectors and compositions and methods of use thereof
TREVENA INC4 citations83
US11077098B2Aug 3, 2021
Opioid receptor ligands and methods of using and making same
TREVENA INC2 citations72
US11931350B2Mar 19, 2024
Opioid receptor ligands and methods of using and making same
TREVENA INC0 citations62
US8993511B2Mar 31, 2015
β-arrestin effectors and compositions and methods of use thereof
TREVENA INC2 citations62
US8946142B2Feb 3, 2015
Beta-arrestin effectors and compositions and methods of use thereof
TREVENA INC3 citations62
US10588898B2Mar 17, 2020
Opioid receptor ligands and methods of using and making same
TREVENA INC0 citations51
BRISTOL MYERS SQUIBB CO
6 patentsUS7439246B2Oct 21, 2008
Fused heterocyclic kinase inhibitors
BRISTOL MYERS SQUIBB CO30 citations92
US6740649B2May 25, 2004
Cyclic hydroxamic acids as inhibitors of matrix metalloproteinases and/or TNF- α converting enzyme (TACE)
BRISTOL MYERS SQUIBB CO31 citations92
US7173031B2Feb 6, 2007
Pyrrolotriazine kinase inhibitors
BRISTOL MYERS SQUIBB CO25 citations91
US6995181B2Feb 7, 2006
Modulators of the glucocorticoid receptor and method
BRISTOL MYERS SQUIBB CO23 citations90
US7211671B2May 1, 2007
Substituted 1,3-dihydro-imidazol-2-one and 1,3-dihydro-imidazol-2-thione derivatives as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE)
BRISTOL MYERS SQUIBB CO15 citations83
US7547782B2Jun 16, 2009
Met kinase inhibitors
BRISTOL MYERS SQUIBB CO6 citations62
YAMASHITA DENNIS
3 patentsUS8835488B2Sep 16, 2014
Opioid receptor ligands and methods of using and making same
YAMASHITA DENNIS41 citations96
US9044469B2Jun 2, 2015
Opioid receptor ligands and methods of using and making same
YAMASHITA DENNIS5 citations82
US8486885B2Jul 16, 2013
β-arrestin effectors and compositions and methods of use thereof
YAMASHITA DENNIS7 citations82
SLOAN KETTERING INST CANCER
2 patentsBRISTOL MYERS SQUIBB PHARMA CO
2 patentsUS6825215B2Nov 30, 2004
1,1-disubstituted cyclic inhibitors of matrix metalloproteases and TNF-α
BRISTOL MYERS SQUIBB PHARMA CO5 citations63
US6962938B2Nov 8, 2005
Spiro-cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-α converting enzyme (TACE)
BRISTOL MYERS SQUIBB PHARMA CO0 citations52